Home/Filings/4/0001213900-19-025253
4//SEC Filing

WINDSOR JAMES BRIAN 4

Accession 0001213900-19-025253

CIK 0001733413other

Filed

Dec 2, 7:00 PM ET

Accepted

Dec 3, 7:44 PM ET

Size

5.3 KB

Accession

0001213900-19-025253

Insider Transaction Report

Form 4
Period: 2019-11-29
WINDSOR JAMES BRIAN
DirectorChief Science Officer
Transactions
  • Award

    Stock Options (Right to Buy)

    2019-11-29+3,623139,429 total
    Exercise: $5.00Exp: 2029-10-29Common Stock (3,623 underlying)
Footnotes (1)
  • [F1]25% of the options vest on the first anniversary of the grant and the remainder vest in equal quarterly installments over the next three years.

Issuer

TFF Pharmaceuticals, Inc.

CIK 0001733413

Entity typeother

Related Parties

1
  • filerCIK 0001790933

Filing Metadata

Form type
4
Filed
Dec 2, 7:00 PM ET
Accepted
Dec 3, 7:44 PM ET
Size
5.3 KB